Autoimmune liver disease

Indian Journal of Pediatrics

Volumn 69, Issue 1, 2002, Pages 93-98

  Mieli Vergani, Giorgina ^a   Vergani, Diego ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Etiology; Hepatitis; Liver

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ACUTE HEPATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CONFERENCE PAPER; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER DISEASE; LIVER TRANSPLANTATION; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PORTAL VEIN; SCLEROSING CHOLANGITIS; T LYMPHOCYTE ACTIVATION;

EID: 0036176728     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723785     Document Type: Conference Paper

References (27)

1. Maggiore G, Veber F, Bernard O, Hadchouel M, Homberg JC, Alvarez F et al. Autoimmune hepatitis associated with anti-action antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993; 17(4) : 376-381.
2. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25(3) : 541-547.
3. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH et al. Chronic active hepatitis associated with antiliver/ kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987; 7(6) : 1333-1339.
4. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis [see comments]. N Engl J Med 1995; 333 (15) : 958-963.
5. Alvarez F, Ciocca M, Canero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999; 30(2) : 222-227.
6. Richardson PD, James PD, Ryder SD. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000; 33(3) : 371-375.
7. Dhawan A, Mieli-Vergani G. Mycophenolate mofetil - a new treatment for autoimmune hepatitis? J Hepatol 2000; 33(3) : 480-481.
8. Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J Pediatr 1994; 124(1) : 49-56.
9. Wilschanski M, Chait P, Wade JA, Davis L, Corey M, St Louis P et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995; 22(5) : 1415-1422.
10. el-Shabrawi M, Wilkinson ML, Portmann B, Mieli-Vergani G, Chong SK, Williams R et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92(5 Pt 1) : 1226-1235.
11. McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases [see comments]. Am J Gastroenterol 1998; 93(5) : 777-784.
12. Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24(6) : 699-705.
13. Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992; 37(10) : 1606-1611.
14. Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001; 33(3) : 544-553.
15. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31 : 929-938.
16. Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep 1999; 1(1) : 63-70.
17. Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351(9100) : 409-413.
18. Duclos-Vallee JC, Johanet C, Bach JF, Yamamoto AM. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J Hepatol 2000; 33(1) : 163-166.
19. Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001; 32(2) : 131-136.
20. Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001; 34 : 464-470.
21. Andries S, Casamaiou L, Sempoux C, Burlet M, Reding R, Otte JB et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation (In press).
22. Hernandez Albujar A AE, Salcedo M et al. Autoimmune mediated liver disease after liver transplantation [Abstract]. J Hepatol 1997; 26 : (Suppl)152.
23. Conti F DB, Levillayer H, Gruska J, Weill B, Calmus Y. Autoantibodies after liver transplantation: a marker of allograft disease [Abstract]. J Hepatol 1997; 26 : (Suppl) 150.
24. Bucy RP, Xu XY, Li J, Huang G. Cyclosporin A-induced autoimmune disease in mice. J Immunol 1993; 151(2) : 1039-1050.
25. Hess AD, Fischer AC, Horwitz LR, Laulis MK. Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression. Transplant Proc 1993; 25(5) : 2811-2813.
26. Cooper MH, Hartman GG, Starzl TE, Fung JJ. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc 1991; 23(6) : 3234-3235.
27. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13(4) : 701-706.